CD8+ T cells expressing HER2 CAR T_shGCDH had significantly increased cytotoxicity against target HER2+ SKOV3 ovarian cancer cells when compared to control HER2 CAR T_shNTC cells (Fig. 5e). This evidence concerns the gene CD8A and ovarian cancer.